Woofun AI reports that Jeremy Grantham, co-founder of GMO, characterizes the SpaceX listing as "the craziest IPO in human history", predicting future mockery of its multi-planetary vision. He warns that the market's current enthusiasm may prove overly optimistic, with investors potentially ridiculing the prospectus in five decades.

SpaceX shares have declined approximately 7% from recent peaks to trade near $150, slightly above the $135 listing target. While Wall Street valuations diverge, with Morgan Stanley targeting $300 and Goldman Sachs at $205, Grantham highlights governance risks tied to Elon Musk’s 82% voting control. Although Nasdaq-100 inclusion forces index fund buying, Grantham maintains that long-term challenges remain significant.